Pharmaceutical Technology Editorial Advisory Board

July 31, 2020

Pharmaceutical Technology North America and Pharmaceutical Technology Europe magazines publish contributed technical articles that undergo a double-blind peer-review process involving members of our distinguished Editorial Advisory Boards (EAB). The EAB are specialists representing various facets of the pharmaceutical industry. EAB members review manuscripts, recommend subject matter and answer questions when they arise.

  • James P. Agalloco, President, Agalloco & Associates
  • Larry L. Augsburger, PhD, Professor Emeritus, University of Maryland
  • Reinhard Baumfalk, Head of Product Development, LPS Sartorius
  • Rafael Beerbohm, Head Quality Animal Health for Biologicals Europe, Boehringer Ingelheim GmbH
  • David H. Bergstrom, PhD, Chief Operating Officer, Bridge Therapeutics
  • Phil Borman, Director, DSc, Product Development & Supply, Medicinal Science & Technology, Pharma R&D, GlaxoSmithKline
  • Evonne Brennan, Technical Director-Americas IMCD N.V. Pharmaceutical Division
  • Rory Budihandojo, Independent GMP Consultant
  • Christopher Burgess, Managing Director, Burgess Analytical Consultancy
  • Metin Çelik, PhD, President, Pharmaceutical Technologies International (PTI)
  • Suggy S. Chrai, PhD, President and CEO, Chrai Associates, Inc.
  • Roger Dabbah, PhD, Principal Consultant, Tri-Intersect Solutions
  • Ryan F. Donnelly, Chair in Pharmaceutical Technology, Queens University Belfast
  • Robert Dream, Managing Director, HDR Company
  • Tim Freeman, Managing Director, Freeman Technology
  • Sanjay Garg, PhD, Professor, Pharmaceutical Sciences, University of South Australia
  • Filipe Gaspar, Vice-President R&D, Hovione
  • Sharon Grimster, VP Development and General Manager, ReNeuron
  • Anne Marie Healy, Professor in Pharmaceutics and Pharmaceutical Technology, Trinity College Dublin
  • R. Gary Hollenbeck, PhD, Research Faculty, University of Maryland School of Pharmacy
  • Deirdre Hurley, Senior Director, Plant, Helsinn Birex Pharmaceuticals Ltd
  • Ruey-ching (Richard) Hwang, PhD, Executive Director, Clinical Supply Operations, Pfizer Global R&D
  • Makarand Jawadekar, Independent Consultant
  • Henrik Johanning, CEO, Senior Consultant, Geneau & More A/S
  • Maik Jornitz, President, G-CON Manufacturing Inc
  • Mansoor A. Khan, PhD, Professor & Vice Dean, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center
  • Marina Levina, Product Owner, GlaxoSmithKline
  • Russell E. Madsen, President, The Williamsburg Group, LLC
  • Heidi M. Mansour, PhD, RPh, Professor, University of Arizona, College of Pharmacy
  • Roberto Margarita, Platform Director, Cordon Pharma
  • Luigi G. Martini, Chair of Pharmaceutical Innovation, King's College London
  • Jim Miller, Advisor on Bio/Pharmaceutical Manufacturing Strategy
  • Colin Minchom, PhD, CMC Consultant
  • Cliff Mintz, President and Founder, BioInsights Inc
  • R. Christian Moreton, PhD, Vice-President, Pharmaceutical Sciences, FinnBrit Consulting
  • Fernando J. Muzzio, PhD, Director, NSF Engineering Research, Center on Structured Organic Particulate Systems, Department of Chemical and Biochemical Engineering,Rutgers University
  • Moheb M. Nasr, PhD, Principal, Nasr Pharma Regulatory Consulting
  • Ian Pearson, Executive General, Manager-Consulting, Derell Consultants
  • Tim Peterson, Technical Manager at Kindeva Drug Delivery
  • John Pritchard, Owner, Inspiring Strategies
  • Thomas Rades, Professor, Research Chair in Formulation, Design and Drug Delivery, University of Copenhagen
  • Jean Paul Remon, Full Professor of Pharmaceutical Technology, Ghent University, Belgium
  • Rodolfo Romañach, Professor of Chemistry, University of Puerto Rico
  • Beatriz San Martin, Partner, Arnold & Porter Kaye Scholer LLP
  • Wendy Saffell-Clemmer, Lead Scientist and Sr. Director, Baxter Healthcare
  • Gurvinder Singh Rekhi, PhD, Department of Pharmaceutical and Biomedical Sciences, The University of Georgia College of Pharmacy
  • Siegfried Schmitt, Vice President Technical, PAREXEL International
  • Susan J. Schniepp, Fellow, Regulatory Compliance Associates, Inc.
  • David R. Schoneker, President, Black Diamond Regulatory Consulting
  • Stane Srcic, Professor, University of Ljubljana, Solvenia
  • Aloka Srinivasan, PhD, Principal and Managing Partner, RAAHA LLC
  • Griet Van Vaerenbergh, Trials & Training Coordinator, GEA Process Engineering
  • Andreas Weiler, Global Head External Supply Cell & Gene Therapy, Novartis
  • Tony Wright, CEO, Exelsius